Nabiqasim Group

Nabiqasim Group, with the slogan "Your Health Our Devotion," has been a key player in the pharmaceutical industry for over 4 decades. The company, through its subsidiary Surge Laboratories (Pvt) Limited, focuses on manufacturing and marketing branded generics and Microencapsulated APIs in various global markets, including Asia, the Middle East, CIS, Africa, Europe, and South America. Surge Laboratories has made significant strides in the industry, particularly through the acquisition of cutting-edge microencapsulation technology from Germany, enabling the company to perform various microencapsulation operations under strict cGMP compliant conditions on a commercial scale. Additionally, Surge Laboratories boasts a dedicated micro-encapsulation development lab, where a specialized team works on developing new formulations to meet customer requirements on a self-contained lab-scale equipment. Nabiqasim Group's commitment to excellence and innovation is evident through its continuous efforts in introducing the latest technologies and providing high-quality pharmaceutical products. The company's dedication to maintaining standards of excellence in pharmaceutical manufacturing has positioned it as a prominent player in the industry. Founded in 1967, Nabiqasim Group operates in the fields of Biotechnology, Health and Wellness, Industrial, Manufacturing, and Marketing. The company's website can be accessed at www.nabiqasim.com. While specific details regarding headquarters, last investment, and investors aren't available, the company's strong track record and focus on technological advancement make it an intriguing prospect for potential investors in the health and wellness sector.